AI in Healthcare March 25, 2021
The FDA has granted 510(k) clearance to clinical decision support software that uses AI to detect small but potentially cancerous lesions in the lungs.
U.K.-based Optellum says its Virtual Nodule Clinic is the first product to gain an FDA nod for applying AI to diagnose lung cancer early in its development.
The software computes a cancer-prediction score from patterns of 3D pixels on images acquired from standard CT scanners.
Optellum’s announcement quotes pulmonologist Anil Vachani, MD, of the University of...